Editing the skin in place: In vivo genome correction of rare skin disease

Key Points

• Genome correction effectively addresses the underlying cause of the rare skin disease, enhancing treatment prospects.
• The approach demonstrates successful editing at the molecular level, highlighting the potential for gene therapy.
• In vivo genome correction achieved significant improvements in skin conditions, indicating a direct impact on pathology.
• This study may enable advancements in treating rare disorders, necessitating further clinical exploration.